+7,32%

General Motors

This trade wasn’t easy, so we are especially proud that we assessed all the risks correctly and did not flinch when the market went against us. We bought these shared in the summer on the rising business market… but the strain of coronavirus made its correctives. Nevertheless, we trusted the process and despite the initial bump, we closed this deal with a 7.32% ROI in autumn.

+17,7%

Moderna

A perfect trade, where correct technical analysis, quick news assessment, and a bit of luck coincided. We brought Moderna shares during the new wave of disturbing news regarding the spread of the virus in the US… however, the initial growth was doubled by the media publications about the new omicron strain, which dramatically shifted shares value. Results? Almost 18% in 4 days.

+8,1%

JOVY

Reuters wrote that top shareholders of JOVY were planning to buy back its major market shares. However, the market had doubts about it, since shortly before it there was a similar rumor about another Chinese company… that rumor turned out to be just a rumor, thus prices fell down. While the majority of investors were in doubt, we hurried up to buy JOYY shares at the given price, since our technical analysis showed us that this time the rumor would not be just a rumor. Well, that was a correct assessment, since we made 8.1% in a week.